fig1

Emerging role of nuclear factor erythroid 2-related factor 2 in the mechanism of action and resistance to anticancer therapies

Figure 1. Plausible mechanisms of cancer drug resistance. The mechanisms can generally be classified as pharmacological and cellular physiological mechanisms, which either feed into or feed out of the well-known and characterised hallmarks of cancer[12]

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/